Shikata, Kenichi
Okayama University Hospital
4 papers on CoChatORCID 0000-0003-3598-636X
Most cited papers
- Verified
Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes
Kodera, R., Shikata, K., Kataoka, H. U., Takatsuka, T., Miyamoto, S., Sasaki, M., Kajitani, N., Nishishita, S., Sarai, K., Hirota, D., et al. (2011) · Diabetologia
Chronic Kidney Disease and DiabetesDiabetes Treatment and Management
Cited by 394
- Verified · note
Esaxerenone (CS-3150) in Patients with Type 2 Diabetes and Microalbuminuria (ESAX-DN): Phase 3 Randomized Controlled Clinical Trial
Ito, S., Kashihara, N., Shikata, K., Nangaku, M., Wada, T., Okuda, Y., & Sawanobori, T. (2020) · Clinical Journal of the American Society of Nephrology
Chronic Kidney Disease and DiabetesAcute Kidney Injury Research
Cited by 234
- Verified · note
Efficacy and Safety of Esaxerenone (CS-3150) for the Treatment of Type 2 Diabetes with Microalbuminuria: A Randomized, Double-Blind, Placebo-Controlled, Phase II Trial
Ito, S., Shikata, K., Nangaku, M., Okuda, Y., & Sawanobori, T. (2019) · Clinical Journal of the American Society of Nephrology
Chronic Kidney Disease and DiabetesHormonal Regulation and Hypertension
Cited by 107
- Verified
Dipeptidyl peptidase-4 inhibitor ameliorates early renal injury through its anti-inflammatory action in a rat model of type 1 diabetes
Kodera, R., Shikata, K., Takatsuka, T., Oda, K., Miyamoto, S., Kajitani, N., Hirota, D., Ono, T., Usui, H. K., & Makino, H. (2014) · Biochemical and Biophysical Research Communications
Chronic Kidney Disease and DiabetesDiabetes Treatment and Management
Cited by 101
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free